Evoke Pharma, Inc. (EVOK)
10.93
0.00 (0.00%)
USD |
NASDAQ |
Dec 09, 16:00
10.92
-0.01
(-0.09%)
After-Hours: 20:00
Evoke Pharma EPS Diluted (Quarterly): -0.4521 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Tactile Systems Technology, Inc. | 0.3646 |
| Sarepta Therapeutics, Inc. | -1.795 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.156M |
| Revenue (Quarterly) | 4.284M |
| Total Expenses (Quarterly) | 5.440M |
| Enterprise Value | 12.36M |
| Gross Profit Margin (Quarterly) | 97.62% |
| Profit Margin (Quarterly) | -26.99% |
| Earnings Yield | -21.80% |
| Normalized Earnings Yield | -21.80 |